Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-12

Clinical Trial Update: The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effectiveness and safety of donepezil hydrochloride (E2020) in adults with mild to severe Alzheimer's disease residing in assisted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Donepezil hydrochloride (Donepezil hydrochloride)

Snippet

Sponsor: Eisai Inc. | Conditions: Mild to Severe Alzheimer's Disease | Phase 4 | Status: COMPLETED | Results posted: 2018-03-12